查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1122435

伤寒疫苗市场：按疫苗类型、给药途径、地区 - 规模、份额、前景和机会分析，2022-2030

Typhoid Fever Vaccines Market, by Vaccine Type, by Route of Administration, and by Region - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
出版日期: | 出版商: Coherent Market Insights | 英文 177 Pages | 商品交期: 2-3个工作天内

价格
简介目录

伤寒是一种由伤寒沙门氏菌引起的细菌感染，会引起长时间发烧、头痛、噁心、食慾不振、便秘，有时还会出现腹泻等症状。细菌通常通过摄入受污染的食物或水通过口腔进入体内，穿透肠壁，并在淋巴组织中繁殖。然后它进入血液并引起菌血症。饮用受污染的水或食用用受污染的水清洗过的食物的人可能会患上伤寒。伤寒主要发生在卫生条件差、没有干净饮用水的地区。伤寒疫苗是一种生物製剂，可以免疫并保护患者免受伤寒的侵害。

目前，世界卫生组织（WHO）推荐以下三种伤寒疫苗。

  • 可注射的伤寒结合疫苗 (TCV) 结合了 Vi 多醣抗原和破伤风类毒素蛋白，已获准用于 6 个月大的儿童和 45 岁或以下的成人。
  • 用于 2 岁及以上儿童的使用纯化 Vi 抗原的可注射非结合多醣疫苗（通常称为 Vi-PS 疫苗），以及
  • 适用于 6 岁及以上儿童的胶囊剂型口服 Ty21a 减毒活疫苗。

市场动态

政府和其他各种组织增加举措以提高对伤寒疫苗的认识，以及增加获得新疫苗的机会，预计将在预测期内推动伤寒疫苗市场的增长。例如，2019 年 2 月，疫苗联盟 Gavi 与世卫组织、疾病控制和预防中心以及津巴布韦卫生部合作，发起了一场抗击津巴布韦伤寒疫情的运动。 Gavi，疫苗联盟是一个公私合作伙伴关係，帮助为世界上一半的儿童接种疫苗以对抗世界上最致命的疾病。该活动的目标是在津巴布韦首都附近的九个地点使用新的伤寒结合疫苗 (TCV) 覆盖 325,000 人。全世界至少有 1240 万儿童被归类为“零剂量”，他们生活在孤独的社区，无法获得包括医疗保健在内的许多基本服务。

本研究的主要特点

  • 本报告对全球伤寒疫苗市场进行了深入分析，提供了以 2021 年为基准年的预测期间（2022-2030 年）的市场规模和復合年增长率 (CAGR%)。
  • 解释不同细分市场的潜在收入机会，并描述该市场具有吸引力的投资建议矩阵。
  • 它还提供了有关市场驱动因素、限制因素、机会、新产品发布或批准、市场趋势、区域前景以及主要参与者采用的竞争策略的重要见解。
  • 根据公司亮点、产品组合、关键亮点、财务业绩和战略等参数对全球伤寒疫苗市场的主要参与者进行了分析。
  • 本研究涵盖的主要公司包括GlaxoSmithKline Plc., Sanofi SA, Bharat Biotech, Bio-Med Pvt. Ltd., PT Bio Farma, PaxVax, Inc. Shanghai Institute of Biological Products Co., Ltd., 和 Prokarium.
  • 本报告中的见解将使营销人员和公司高管能够就未来的产品发布、类型升级、市场扩张和营销策略做出明智的决策。
  • 全球伤寒疫苗市场报告迎合了该行业的各种利益相关者，包括投资者、供应商、产品製造商、分销商、新进入者和财务分析师。
  • 利益相关者可以通过用于分析全球伤寒疫苗市场的各种战略矩阵来促进他们的决策。

内容

第 1 章目的和先决条件

  • 调查目的
  • 先决条件
  • 缩写说明

第二章市场展望

  • 举报内容
    • 市场定义和范围
  • 执行摘要
    • 市场快照：按疫苗类型
    • 按管理途径划分的市场概况
    • 市场概况：按地区划分
  • 连贯的机会图 (COM)

第 3 章市场动态、法规和趋势分析

  • 市场动态
    • 驱动程序
    • 限制因素
    • 市场机会
  • 影响分析
  • 新产品发布/批准
  • PEST 分析
  • 意识提升策略
  • 保险报销场景
  • 伤寒疫苗短缺
  • 临床试验分析
  • 蛇咬伤事故多发的国家
  • 市场进入挑战

第 4 章全球伤寒疫苗市场 - 冠状病毒 (COVID-19) 大流行的影响

  • 整体影响
  • 政府举措
  • COVID-19 对市场的影响

第 5 章全球伤寒疫苗市场：按疫苗类型，2017-2030 年

  • 减毒活疫苗
  • 荚膜多醣疫苗
  • 结合疫苗
  • 其他

第 6 章按管理途径分列的全球伤寒疫苗市场：2017-2030 年

  • 口服给药
  • 父母

第 7 章全球伤寒疫苗市场：2017-2030 年各地区

  • 北美
  • 美国
  • 加拿大
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲地区
  • 欧洲
  • 英国
  • 德国
  • 意大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲
  • 亚太地区
  • 中国
  • 印度
  • 日本
  • 东盟
  • 澳大利亚
  • 韩国
  • 其他亚太地区
  • 中东
  • 海合会
  • 以色列
  • 其他中东
  • 非洲
  • 北非
  • 中非
  • 南非

第 8 章竞争格局

  • 热图分析
  • 公司简介
    • GlaxoSmithKline Plc.
    • Sanofi SA
    • Bharat Biotech
    • Bio-Med Pvt. Ltd.
    • PT Bio Farma
    • PaxVax, Inc.
    • Shanghai Institute of Biological Products Co., Ltd.
    • Prokarium

第九章章节

  • 参考资料
  • 调查方法
简介目录
Product Code: CMI2552

Typhoid fever is a bacterial infection caused by Salmonella typhi, which causes symptoms such as prolonged fever, headache, nausea, loss of appetite, and constipation or sometimes diarrhea. The bacterium usually enters the body through the mouth by the ingestion of contaminated food or water, penetrates the intestinal wall, and multiplies in lymphoid tissue. It then enters the bloodstream and causes bacteremia. People who drink contaminated water or eat food washed in contaminated water can develop typhoid fever. Typhoid fever is majorly caused in area with poor sanitation and lack of clean drinking water. Typhoid fever vaccines are the biological formulations, which provide immunity and protect an individual against typhoid fever.

Currently there are three typhoid vaccines recommended by the World Health organization (WHO) for use which include:

  • Injectable typhoid conjugate vaccine (TCV), consisting of Vi polysaccharide antigen linked to tetanus toxoid protein licensed for children from 6 months of age and adults up to 45 years of age
  • Injectable unconjugated polysaccharide vaccine based on the purified Vi antigen (known as Vi-PS vaccine) for persons aged two years and above, and
  • Oral live attenuated Ty21a vaccine in capsule formulation for those over six years of age

Market Dynamics

Increasing initiatives by governments and various other organizations to increase awareness about typhoid vaccine and rising access of new vaccines is expected to drive the typhoid fever vaccines market growth during forecast period. For instance, in February 2019, Gavi, the Vaccine Alliance in partnership with WHO, Center for Disease Control and Prevention and Zimbabwe's Ministry of Health launched a campaign to tackle typhoid outbreak in Zimbabwe. Gavi, the Vaccine Alliance is a public-private partnership that helps vaccinate half the world's children against some of the world's deadliest diseases. The campaign aims to vaccinate 325,000 people in nine suburbs of Zimbabwe's capital with new typhoid conjugate vaccine (TCV). At least 12.4 million children worldwide are categorized as 'zero-dose', living in missed communities that cannot access many essential services, including health care.

Key features of the study:

  • This report provides an in-depth analysis of the global typhoid fever vaccines market, and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022-2030), considering 2021 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
  • It profiles key players in the global typhoid fever vaccines market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
  • Key companies covered as a part of this study include GlaxoSmithKline Plc., Sanofi SA, Bharat Biotech, Bio-Med Pvt. Ltd., PT Bio Farma, PaxVax, Inc. Shanghai Institute of Biological Products Co., Ltd., and Prokarium.
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
  • The global typhoid fever vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global typhoid fever vaccines market

Detailed Segmentation:

  • Global Typhoid Fever Vaccines Market, By Vaccine Type:
    • Live Attenuated Vaccine
    • Capsular Polysaccharide Vaccines
    • Conjugate Vaccine
    • Others
  • Global Typhoid Fever Vaccines Market, By Route of Administration:
    • Oral
    • Parenteral
  • Global Typhoid Fever Vaccines Market, By Region:
    • North America
      • By Country
    • U.S.
    • Canada
    • Latin America
      • By Country
    • Brazil
    • Mexico
    • Argentina
    • Rest of Latin America
    • Europe
      • By Country
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
    • Asia Pacific
      • By Country
    • China
    • India
    • Japan
    • Australia
    • South Korea
    • ASEAN
    • Rest of Asia Pacific
    • Middle East
      • By Country
    • GCC
    • Israel
    • Rest of Middle East
    • Africa
      • By Region
    • South Africa
    • Central Africa
    • North Africa
  • Company Profiles
    • GlaxoSmithKline Plc.*
      • Company Highlights
      • Products Portfolio
      • Key Highlights
      • Financial Performance
      • Strategies
    • Sanofi SA
    • Bharat Biotech
    • Bio-Med Pvt. Ltd.
    • PT Bio Farma
    • PaxVax, Inc.
    • Shanghai Institute of Biological Products Co., Ltd.
    • Prokarium

"*" marked represents similar segmentation in other categories in the respective section.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Vaccine Type
    • Market Snapshot, By Route of Administration
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Market Opportunities
  • Impact Analysis
  • Novel Product Launch/Approval
  • PEST Analysis
  • Awareness Strategy
  • Reimbursement Scenario
  • Typhoid Fever Vaccines Shortage
  • Clinical Trial Analysis
  • Countries with High Number of Incidents of Snake Bites
  • Market Entry Challenges

4. Global Typhoid Fever Vaccines Market- Impact of Coronavirus (Covid-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the market

5. Global Typhoid Fever Vaccines Market, By Vaccine Type, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Live Attenuated Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Capsular Polysaccharide Vaccines
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Conjugate Vaccine
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

6. Global Typhoid Fever Vaccines Market, By Route of Administration, 2017 - 2030, (US$ Million)

  • Overview
    • Market Share Analysis, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, 2017 - 2030
    • Segment Trends
  • Oral
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)
  • Parental
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2017-2030, (US$ Million)

7. Global Typhoid Fever Vaccines Market, By Region, 2017 - 2030, (US$ Million)

  • Introduction
    • Market Share Analysis, By Region, 2022 and 2030 (%)
    • Y-o-Y Growth Analysis, For Regions, 2017-2030
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.S.
  • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • China
  • India
  • Japan
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2017 - 2030, (US$ Million)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Vaccine Type, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2017 - 2030, (US$ Million)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2017 - 2030, (US$ Million)
  • North Africa
  • Central Africa
  • South Africa

8. Competitive Landscape

  • Heat Map Analysis
  • Company Profiles
    • GlaxoSmithKline Plc.
  • Company Highlights
  • Product Portfolio
  • Key Highlights
  • Financial Performance
  • Strategies
    • Sanofi SA
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Bharat Biotech
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Bio-Med Pvt. Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • PT Bio Farma
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • PaxVax, Inc.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Shanghai Institute of Biological Products Co., Ltd.
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies
    • Prokarium
  • Company Overview
  • Product Portfolio
  • Key Developments
  • Financial Performance
  • Strategies

9. Section

  • References
  • Research Methodology
  • About Us and Sales Contact